objective to describe the attitudes and behaviours regarding placebo treatments defined as a treatment whose benefits derive from positive patient expectations and not from the physiological mechanism of the treatment itselfdesign cross sectional mailed surveysetting physicians clinical practicesparticipants 1200 practising internists and rheumatologists in the united statesmain outcome measures investigators measured physicians self reported behaviours and attitudes concerning the use of placebo treatments including measures of whether they would use or had recommended a placebo treatment their ethical judgments about the practice what they recommended as placebo treatments and how they typically communicate with patients about the practiceresults 679 physicians 57 responded to the surveyabout half of the surveyed internists and rheumatologists reported prescribing placebo treatments on a regular basis 4658 depending on how the question was phrasedmost physicians 399 62 believed the practice to be ethically permissiblefew reported using saline 18 3 or sugar pills 12 2 as placebo treatments while large proportions reported using over the counter analgesics 267 41 and vitamins 243 38 as placebo treatments within the past yeara small but notable proportion of physicians reported using antibiotics 86 13 and sedatives 86 13 as placebo treatments during the same periodfurthermore physicians who use placebo treatments most commonly describe them to patients as a potentially beneficial medicine or treatment not typically used for their condition 241 68 only rarely do they explicitly describe them as placebos 18 5conclusions prescribing placebo treatments seems to be common and is viewed as ethically permissible among the surveyed us internists and rheumatologistsvitamins and over the counter analgesics are the most commonly used treatmentsphysicians might not be fully transparent with their patients about the use of placebos and might have mixed motivations for recommending such treatments